MedPath

Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse

Phase 1
Completed
Conditions
Opioid Dependence
Cocaine Abuse
Registration Number
NCT00292123
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Brief Summary

The primary goal of this study is to determine how contingency management can best be combined with standard or high doses of methadone to increase simultaneous abstinence from heroin and cocaine.

Detailed Description

A study of people pmaintained on Methadone using contingency management

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Opioid dependence; cocaine use
Exclusion Criteria
  • Medical or psychiatric conditions that would contraindicate participation in a methadone maintenance study; inability to give informed consent; inability to attend clinic seven days a week

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath